Discontinued — last reported Q4 '25
Ameren Accrued Proceeds from Issuance of Common Stock remained flat by 0.0% to $7.00M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Accrued Proceeds from Issuance of Common Stock shows a downward trend with a -4.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher amounts indicate pending cash inflows from recent equity financing activities.
This represents cash or receivables related to common stock issuances that have been earned but not yet fully settled or...
Common in companies frequently utilizing equity markets; peers report this as part of their financing cash flow or balance sheet adjustments.
other_accrued_proceeds_from_issuance_of_common_stock| Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|
| Value | $8.00M | $7.00M | $7.00M | $7.00M |
| QoQ Change | — | -12.5% | +0.0% | +0.0% |
| YoY Change | — | -12.5% | +0.0% | +0.0% |